VIDO is a global leader in human and animal infectious disease research and vaccine development. We conduct research from discovery through to preclinical (human) and full-clinical trials (animal).

Our research is organized into the following programs:

• Bacterial Vaccine Development
• Viral Vaccine Development
• Vaccine Formulation and Delivery
• Clinical Research and Animal Care

All Diseases We Study

• Human Diseases
  • COVID-19 
  • Gastroenteritis (Campylobacter, E. coli, Salmonella, Salmonella biofilms) 
  • Gonorrhea
  • Influenza
  • Long COVID
  • MERS
  • Parainfluenza
  • RSV
  • TB Vaccine and Drug Development / TB Treatment 
  • Whooping cough
  • Zika
• Cattle Disease
  • Bovine leukosis
  • Bovine respiratory disease(Histophilus somni)
  • Bovine TB
  • Chronic pneumonia(Mycoplasma bovis)
  • Contagious bovine pleuropneumonia
  • Johne's disease
  • Pink eye
  • Shipping fever
• Swine Diseases
  • African swine fever
  • Ileitis(Lawsonia intracellularis)
  • Porcine epidemic diarrhea
  • Porcine reproductive and respiratory syndrome
  • Respiratory diseases
  • Swine influenza
• Poultry Diseases
  • Yolk sac infection
• Alternative Livestock Diseases
  • Chronic wasting disease
  • Sheep and goat footrot
  • Sheep respiratory diseases
• Platform Technologies
  • Adenovirus vectors
  • Development of novel combination adjuvants
  • Intestinal immunity
  • Intrauterine immunization
  • Kinome analysis
  • Neonatal mucosal immunity

VIDO’s Scientific Advisory Board provides input into our strategic research direction helping to identify current gaps and contributing to awareness and assessment of new opportunities. The members of the Advisory Board are leading international experts in human and animal health research.